- Home
- OST vs ALZN Comparison
OST vs ALZN Comparison
Compare OST & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- ALZN
- Stock Information
- Founded
- OST 2010
- ALZN 2016
- Country
- OST China
- ALZN United States
- Employees
- OST N/A
- ALZN N/A
- Industry
- OST Industrial Machinery/Components
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- OST Technology
- ALZN Health Care
- Exchange
- OST Nasdaq
- ALZN Nasdaq
- Market Cap
- OST 5.7M
- ALZN 6.9M
- IPO Year
- OST 2022
- ALZN 2021
- Fundamental
- Price
- OST $0.41
- ALZN $1.64
- Analyst Decision
- OST
- ALZN
- Analyst Count
- OST 0
- ALZN 0
- Target Price
- OST N/A
- ALZN N/A
- AVG Volume (30 Days)
- OST 83.1K
- ALZN 361.1K
- Earning Date
- OST 08-26-2024
- ALZN 12-13-2024
- Dividend Yield
- OST N/A
- ALZN N/A
- EPS Growth
- OST N/A
- ALZN N/A
- EPS
- OST N/A
- ALZN N/A
- Revenue
- OST $38,203,634.00
- ALZN N/A
- Revenue This Year
- OST N/A
- ALZN N/A
- Revenue Next Year
- OST N/A
- ALZN N/A
- P/E Ratio
- OST N/A
- ALZN N/A
- Revenue Growth
- OST N/A
- ALZN N/A
- 52 Week Low
- OST $0.27
- ALZN $1.40
- 52 Week High
- OST $1.07
- ALZN $33.00
- Technical
- Relative Strength Index (RSI)
- OST 61.31
- ALZN 40.84
- Support Level
- OST $0.38
- ALZN $1.58
- Resistance Level
- OST $0.44
- ALZN $1.90
- Average True Range (ATR)
- OST 0.04
- ALZN 0.14
- MACD
- OST 0.00
- ALZN 0.05
- Stochastic Oscillator
- OST 77.14
- ALZN 39.53
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.